Accurate measurement of testosterone is important for reproductive endocrinology research, but the validity of direct (nonextraction) testosterone immunoassays, developed and validated for human serum, has not been appraised for application to mouse serum or steroidogenic tissue extracts. Testosterone was measured in serum and extracts of testis or ovary from male and female wild-type mice by 2 commercial direct testosterone immunoassays, with and without preassay extraction, and by the liquid chromatography, tandem mass spectrometry reference method. Results were compared hierarchically by correlation (Kendall's ), regression (Passing-Bablok), and deviance (Bland-Altman) analysis, under the null hypothesis of perfect agreement between assays (slope ϭ 1, intercept and deviation ϭ 0). For mouse serum, immunoassays displayed an upward bias with performance better for male vs female sera and, within gender, improved by preassay extraction relative to liquid chromatography, tandem mass spectrometry. Testosterone was detectable in all serum samples, but few (male 54%, female 9%) were accurate (within 20% of the reference measurement). For mouse testis extracts, immunoassays were biased upwards, and preassay extraction improved immunoassay performance. Although testosterone was detectable in all extracts, a minority (45%) was accurate. For mouse ovary extracts, all correlations were poor with severe, upward bias, and while testosterone was detectable in all samples, virtually none were accurate. We conclude that these direct testosterone immunoassay kits provide relatively, but not absolutely, accurate results with male mouse serum and testis extracts but not with female mouse serum and ovary extracts, with performance improved by preassay extraction. Whether relative accuracy is fit for purpose depends on the experimental aims, design, and interpretation. (Endocrinology 156: 400 -405, 2015) T estosterone is the principal mammalian androgen. It is not only pivotal for male sexual differentiation, development, and function (1) but also involved in the hyperandrogenism observed in women with polycystic ovary syndrome, among the most frequent forms of female reproductive pathology (2), and recent research proves that androgen action is essential for optimal female reproductive function (3). Hence, accurate measurement of testosterone is essential for understanding reproductive physiology, as well as diagnosis and monitoring of reproductive pathophysiology and treatments. Because definitive experimental research in humans is limited by ethical and logistic limitations, the versatility of mouse models, notably their adaptability to customized genetic targeting, makes accurate characterization of murine reproductive function of critical importance in both male and female reproductive research.
T estosterone is the principal mammalian androgen. It is not only pivotal for male sexual differentiation, development, and function (1) but also involved in the hyperandrogenism observed in women with polycystic ovary syndrome, among the most frequent forms of female reproductive pathology (2) , and recent research proves that androgen action is essential for optimal female reproductive function (3) . Hence, accurate measurement of testosterone is essential for understanding reproductive physiology, as well as diagnosis and monitoring of reproductive pathophysiology and treatments. Because definitive experimental research in humans is limited by ethical and logistic limitations, the versatility of mouse models, notably their adaptability to customized genetic targeting, makes accurate characterization of murine reproductive function of critical importance in both male and female reproductive research.
Specific measurement of testosterone first became feasible with the invention of steroid immunoassay (4, 5) , a decade after the invention of peptide immunoassay (6) .
This delay was required to ensure validity of an immunoassay for a small, nonimmunogenic molecule like testosterone, which was achieved by employing a triplet of additional steps, extraction, chromatography and structurally authentic tracers. These steps overcame cross-reaction from structurally related steroids (eg, precursors and metabolites) and nonspecific matrix effects (7) . However, the high demand for testosterone measurement in clinical practice led to simplification of testosterone immunoassays to enable their incorporation into high throughout multiplex immunoassay platforms and singletube kits, which, however, required discarding all the triplet validity criteria into direct (ie, nonextraction) testosterone immunoassays. It is now well established that, relative to mass spectrometry (MS)-based reference methods, modern direct testosterone immunoassays exhibit method-specific bias (8 -10) , such that they are not accurate or reliable at low prevailing circulating serum testosterone concentrations, such as in children, women, and hypogonadal men (11) .
Direct testosterone immunoassays incorporate nondisclosed proprietary steroid-like reagents to block testosterone binding to SHBG and are optimized for fixed, small volumes of human serum. However, steroidogenic tissue extracts feature a spectrum of potentially cross-reacting steroids that differ widely from human serum. Unlike human serum, mouse serum lacks any circulating SHBG, because the murine liver does not secrete a ABP/SHBG (12) . Hence, the validity of commercial direct testosterone immunoassays requires verification when used with nonhuman sera or steroidogenic tissue extracts. Although one study systematically evaluated the analogous direct estradiol immunoassays for use with mouse serum (13) , to our knowledge, there are no reported evaluations of the validity of commercial direct testosterone immunoassays in mice. Hence, we have undertaken an evaluation of the validity of commercial direct testosterone immunoassays for use with mouse serum or extracts of testis and ovary.
Materials and Methods

Mice
Heathy wild-type male (n ϭ 20) and female (n ϭ 20) mice were obtained from the ANZAC Research Institute colony, where they were bred and housed under standard animal house conditions with food and water ad libitum in a humidity-controlled 12-hour light, 12-hour dark cycle. Mice were killed under anesthesia with blood (1 mL) obtained by cardiac puncture and the testes or ovaries excised, weighed, and snap frozen. Serum was stored at Ϫ20°C until assay.
Frozen tissue samples (whole testis or ovary, both from 10 individual mice) were transferred into 5-mL glass tubes containing buffer (500 L for testis, 300 L for ovary; 0.5% bovine serum albumin [wt/vol], 5mM EDTA in PBS [pH 7.4]) and homogenized on ice for 20 seconds using an IKA T10 basic disperser on the highest setting as described previously (14) . The dispersion probe was cleaned of residual tissue and rinsed in PBS between samples. Homogenates were centrifuged at 3000 rpm (IEC PR-7000 centrifuge, 2700g) for 10 minutes at 4°C to sediment the insoluble debris, and supernatants were transferred to fresh 1.5-mL plastic tubes for storage at Ϫ80°C until analysis.
Assays
Serum testosterone was measured in 100-L serum, 100 L of testis extract, or 200-L ovary extract by liquid chromatography, tandem mass spectrometry as described (15) and modified and validated for mouse serum (14) as well as by 2 commercial direct testosterone immunoassays, the DELFIA (D) (PerkinElmer Life Sciences) and Sapphire (S) (Cayman Chemical Co) purchased from local suppliers. Direct testosterone assays were performed using unextracted serum samples (25 L for D, 50 L for S) in duplicate and processed as per the manufacturer's protocols. The same samples were also rerun after extraction with ethyl acetate:hexane (2:3) after addition of twice their volume of organic solvent in borosilicate 12 ϫ 75-mm test tubes. After vigorous vortexing, tubes were allowed to separate into 2 phases, and the organic phase was transferred to a new borosilicate tube. The organic solvent was allowed to evaporate to dryness and the residue reconstituted to the original volume with homogenization buffer. Extraction efficiency was estimated by spiking an additional serum aliquot with tritiated testosterone (1,2,6,7 tritiated testosterone, 3.45 TBq/mmole from PerkinElmer; 10 000 cpm in 5-L ethanol). The recovery aliquot was vortexed and allowed to equilibrate at room temperature for 1 hour before organic solvent extraction. The organic layer was transferred to a scintillation vial and the radioactivity counted in a ␤-counter (Packard TRI-CARB 2100TR). Results for each sample and both extraction immunoassays were corrected for recovery (94 Ϯ 5%; mean Ϯ SD%). The coefficients of variation of the LC-MS assay were 3%-13% (n ϭ 10) for within-run and 9%-15% (n ϭ 20) for between-run for 4 levels of quality control (nominal concentrations 0.025, 0.2, 0.8, and 8 ng/mL). For D, the CVs were 3.1% (n ϭ 32) within-assay and 9.1% (n ϭ 21) between assay, and for S, which was run only once in a single batch for this study, the within-assay coefficient of variation was 4.5% (n ϭ 25).
Literature review
In order to evaluate the assay methodologies being used for testosterone measurements, a literature search was conducted. Using a PubMed search for "mouse" plus "testosterone" and restricted to 1) the top experimental journals for reproductive endocrinology (Endocrinology) and biology (Biology of Reproduction), as defined by Web of Science's Eigenfactor score; and 2) papers published from January 1, 2004 to the present (September 2014). Each paper was reviewed (G.K.S.S.) to determine 1) the type of assay used to measure testosterone (immunoassay or LC-MS; direct [unextracted] 
Data analysis
The assay results were compared using 3 methods in a stepwise hierarchical analysis using methods to compare assays that recognized measurement error in both variables. First, the correlation of results was evaluated by Kendall's coefficient to determine whether there was a significant correlation (vs the null hypothesis of 2 unrelated measurements). Second, if 2 assays were significantly correlated, results were compared by nonparametric Passing-Bablok regression to estimate the slope and intercept (with 95% confidence limits) to test the hypothesis of perfect agreement between assays (ie, slope ϭ 1.0, intercept ϭ 0). Finally, results were also compared between methods in a modified deviance (Bland-Altman) analysis, which evaluates scaledependent differences between assays using mass spectrometry as reference method or, for comparisons not including the reference method, the mean of the 2 immunoassays being compared. Better performance of an assay was defined as being closer to the ideal hypothesis of perfect agreement (correlation and regression slope closer to 1.0, regression intercepts and deviations closer to 0 with minimal scatter about the line of identity). Accuracy was estimated as an assay result within 10% or 20% of the reference method result for the same sample.
Results
The literature review revealed that of 246 papers published over the last decade in the 2 surveyed journals, 148 (60%) papers measured testosterone with 89 not measuring testosterone, 8 involving nonmouse samples, and 1 paper was unavailable. Testosterone measurements were performed by immunoassay in 139 papers (94%) and by LC-MS in 9 papers (6%). Immunoassay measurements were performed for serum or plasma (64 direct, 37 indirect), tissue extracts (10 direct, 21 indirect), and medium (16 direct, 7 indirect). The extraction procedures included solvents (dichloromethane, diethyl ether, ethyl acetate, ethanol, chloroform/methanol, hexane/ethyl ether, hexane/ ethyl acetate, and cyclohexane/ethyl acetate) or solid phase methods (Sephadex LH-20; Celite), whereas 6 papers did not specify the extraction method used. List of papers from the literature review are available on request.
Testosterone concentrations in male and female mouse serum and extracts of testis and ovary are shown in Table 1 .
In mouse serum, both direct and extracted immunoassays were correlated with the reference method measurements (Table 2 ), but the correlations were better in male (0.74 -0.93) than female (0.44 -0.75) sera. Each immunoassay, whether extracted preassay or not, was consistently biased upwards. The bias was less for male compared with female sera and was improved by preassay extraction. Testosterone was detectable in all serum samples in each assay, but few samples were accurate, and this was achieved more often with male (26/80, 33% within 10% or 43/80, 54% within 20%) than female (4/80, 5% within 10% or 7/80, 9% within 20%) sera.
In mouse testis extracts, both direct and extracted immunoassays were correlated with the reference method but less well than with male mouse serum ( Table 3 ). There was a uniform upward bias, which was significantly improved with preassay extraction. All samples were detectable for each assay, but few (17/80, 21% within 10% or 36/80, 45% within 20%) were accurate.
In mouse ovary extracts, 2 of the 4 methods displayed no, and a third only a marginally significant, correlation with the reference method, whereas the fourth had a poor (but significant) correlation (Table 3) . Each method had very large upward bias, which was minimally improved by preassay extraction. Although testosterone was detectable in all samples for each assay, virtually none were accurate.
Discussion
This study examined the performance of 2 direct testosterone immunoassays, selected for convenience, from a large number of single-tube kit formats as used ad hoc in many research laboratories. The literature survey suggests that, even in the top specialist journals over the last decade, the vast majority (94%) of papers still uses testosterone immunoassays, with only 6% using LC-MS methods. Of the testosterone immunoassays used, for serum/plasma samples, most used direct (nonextracted) methods, whereas for tissue extracts, extraction was more often used. We used a collection of individual sera and gonadal extracts from male and female mice to create a panel of samples that allow evaluation of the performance of the immunoassays by calibration against the reference LC-MS method, as done to appraise the performance of direct testosterone immunoassays with human sera (10) . Using individual mouse sera, however, made it feasible to test only 3 distinct assays contemporaneously based on the limited volume of serum obtainable from each mouse. Whether equivalent performance applies to the many other kit and multiplex platform formats of direct testosterone immunoassays when used for mouse samples remains to be determined. For mouse serum and testis extracts, immunoassay performance correlated relatively well with the reference method but did not provide accu- A substantial literature in clinical research has recognized the method-specific bias and limited sensitivity and specificity of commercial direct testosterone immunoassays (8 -10) when compared with the MS-based reference methods. However, there is much less awareness of these limitations of direct testosterone immunoassays with samples of nonhuman serum or steroidogenic tissue extracts (14) , and to the best of our knowledge, there are no previous evaluations of the validity of such nonextraction assays with mouse serum or tissue extracts. One study evaluated serum testosterone measurement in 20 male rats using a commercial direct testosterone immunoassay (Siemens coat-a-count kit) also reported a good correlation (r ϭ 0.97), but a substantial upward bias relative to LC-MS measurements (16) was not further quantified nor was the impact of preassay extraction evaluated. More recent newer testosterone immunoassays used for mice have employed preassay solvent extraction (17, 18) , but the results were neither validated in mice nor by a MSbased reference method. Consequently, the report of an apparent strain differences in serum testosterone cannot exclude the possibility of species-dependent nonspecific matrix interference effects (18) . Direct estradiol immunoassays are also reported to exhibit very wide betweenmethod bias and inaccuracy in a study of 8 commercial direct estradiol immunoassays used with serum pools or a limited number of different sets of mouse sera (13) . In that study, the recommended method displayed unsatisfactory (ϳ170%) recovery and was unable to distinguish serum estradiol in intact from ovariectomized females. However, the impact of preassay extraction was not evaluated.
The suboptimal performance of direct testosterone immunoassays is likely to be attributable to their eliminating of the triplet validity criteria for steroid immunoassay. The addition of preassay extraction consistently improved, without fully rectifying, performance in male samples through an effect of reducing nonspecific matrix effects and/or removing cross-reacting water-soluble steroid metabolites (eg, phase II glucuronide and sulfate conjugates). Similar but weaker improvement in performance was also seen with the addition of preassay extraction in female sera and ovary extracts. The superior performance of male serum may be largely attributable to the occasional very high serum testosterone concentrations, the product of the highly pulsatile secretion of testosterone in mice (19, 20) , because the reproducibility of male and female serum samples were equivalent at similar lower circulating testosterone concentrations. This also highlights the limitation of comparing assays solely by correlation as high values wield disproportionate influence inflating the apparent correlation, which tests the inadequate hypothesis that 2 assays are completely unrelated, and more discerning methods such as deviance analysis are required to test the more realistic and discriminating hypothesis that 2 assay for the same variable give identical results. A further systematic limitation of testosterone immunoassays is their single analyte limitation, compared with the multianalyte capabilities of MS-based steroid assays, which is particularly disadvantageous for evaluating androgen status, because it overlooks the fact that male mammals have 2 rather than a single bioactive androgen (21) .
The requirement for absolute accuracy in testosterone immunoassays is highly relevant in clinical practice and research where, as quantitative results of observational research on an individual or research group, need to be considered effectively interchangeable between methods and laboratories and over time. Making decisions based on such testosterone results, detached from their specific origins, requires a high degree of accuracy, such as interlaboratory quality assurance programs are intended to maintain. By contrast, in laboratory experimentation where the use of contemporaneous control group of animals or cells is both mandatory and readily achievable, the requirement for quantitative accuracy may be less stringent with relative accuracy sufficient. In many laboratory research settings, testosterone measurement is required occasionally but not regularly, making a simple kit format desirable. In less common circumstances where the testosterone results may be intended to represent definite quantitative thresholds (eg, toxicology), a higher degree of accuracy, comparable with that required for clinical practice and research, may be required, and in that setting, MS-based methods would be preferable.
We conclude that when compared with the LC-MS reference method, these 2 direct testosterone immunoassays are capable of providing relatively, but not absolutely, accurate results in male mouse serum and testis extracts, especially with the addition of preassay extraction, but not in female mouse serum or ovary extracts. Whether such relative rather than absolute accuracy is fit for purpose depends on the experimental aim, design, and interpretation.
